ISSN 1674-3865  CN 21-1569/R
主管:国家卫生健康委员会
主办:中国医师协会
   辽宁省基础医学研究所
   辽宁中医药大学附属医院

中国中西医结合儿科学 ›› 2025, Vol. 17 ›› Issue (4): 355-358.doi: 10.20274/j.cnki.issn.2025.04.015

• 中医应用研究 • 上一篇    下一篇

基于肺之“玄府-气液-络脉”理论分期辨治小儿支原体肺炎

孙越臣1, 徐茹2, 刘薇薇3, 李亚东3()   

  1. 300120 天津,天津市中医药研究院附属医院肾病科(孙越臣)
    300052 天津,天津医科大学总医院消化科(徐茹)
    300143 天津,天津中医药大学第二附属医院儿科(刘薇薇,李亚东)
  • 收稿日期:2025-01-11 修回日期:2025-06-13 出版日期:2025-08-25 上线日期:2025-08-25
  • 通讯作者: 李亚东 E-mail:liyadong1205@126.com
  • 作者简介:孙越臣(1990-),男,医学硕士,主治医师。研究方向:呼吸、肾脏疾病的中西医结合临床与基础研究
  • 基金资助:
    国家自然科学基金项目(8200152470)

Differential treatment by stages for mycoplasma pneumonia in children based on the theory of "Xuanfu-Qiye-Luomai" of the lung

Yuechen SUN1, Ru XU2, Weiwei LIU3, Yadong LI3()   

  1. 1.Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital,Tianjin 300120,China
    2.Tianjin Medical University General Hospital, Tianjin 300052, China
    3.The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300143, China
  • Received:2025-01-11 Revised:2025-06-13 Published:2025-08-25 Online:2025-08-25
  • Contact: Yadong LI E-mail:liyadong1205@126.com
  • Supported by:
    National Natural Science Foundation of China(8200152470)

摘要:

基于肺之“玄府-气液-络脉”理论,小儿支原体肺炎于内应有络脉虚滞的致病基础,加之热毒侵犯致肺玄府壅塞郁闭,气液宣通失常而发生支原体肺炎。因此在开通玄府、调畅气液、补虚通络治疗的基础上,对支原体肺炎分期论治,初期灵活运用辛味发散药以开通肺玄府,中期巧用清热祛痰药以宣通气液,末期善用补虚通络药以扶助正气,消散玄府内有形无形之邪,使肺玄府得通,气液得畅,以期为辨治小儿支原体肺炎提供新思路。

关键词: 支原体肺炎, 络脉, 肺玄府, 儿童

Abstract:

Based on the theory of "Xuanfu-Qiye-Luomai" of the lung, the pathogenic basis of mycoplasma pneumonia in children should be the deficiency and stagnation of the Luomai inside the body. Moreover, the invasion of heat toxins leads to the congestion and closure of Xuanfu of the lung and the abnormal circulation of Qiye, resulting in mycoplasma pneumonia. Therefore, on the basis of opening Xuanfu, regulating Qiye, and tonifying deficiency and unblocking Luomai, the treatment for mycoplasma pneumonia should be staged. In the initial stage, pungent and dispersing drugs should be flexibly used to open Xuanfu of the lung. In the middle stage, heat-clearing and phlegm-resolving drugs should be skillfully used to promote the circulation of Qiye. In the final stage, drugs for tonifying deficiency and unblocking Luomai should be properly used to support the body's vital energy and eliminate both visible and invisible pathogenic factors within Xuanfu, so as to ensure the opening of Xuanfu and the smooth circulation of Qiye, which is expected to provide a new perspective for the differential treatment of mycoplasma pneumonia in children.

Key words: Mycoplasma pneumonia, Luomai, Xuanfu of the lung, Child

中图分类号: